Iterative Scopes Company
Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.
Investors
Total Funding:
19049241
Investor Type:
For Profit
Last Funding Type:
Series A
Investors Number:
5
Industry:
HealthCare Administration
Technology:
['BioTech & HealthTech']
Founded Date:
2017
Employee Number:
101-250
Estimated Revenue:
Less than $1M
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Early Stage Venture